Entero Healthcare Solutions has received approval for acquisition of Vishal Surgicals and Vishal Surgicals & Medicals, a Partnership Firm, through its subsidiary company Sai Pharma Distributors through Slump Sale / Business Transfer Agreement (BTA).
Vishal Surgicals and Vishal Surgicals & Medicals operate in same line of business activity i.e., business of distribution of pharmaceuticals, surgical and other healthcare and allied products. The business of Vishal Surgicals and Vishal Surgicals & Medicals is in line of the business of the company i.e. wholesale distribution of pharmaceutical, surgical and other allied products and the acquisition of business of the target entities will enable the company to generate additional business and revenue on consolidated basis.
The company shall pay an amount upto Rs 63 million (includes net assets and target-based milestone achievement consideration) for the acquisition of the business of Vishal Surgicals. The company shall pay an amount upto Rs 29.1 million (includes net assets and target-based milestone achievement consideration) for the acquisition of the business of Vishal Surgicals & Medicals. The acquisition shall be completed by December 31, 2026. The Board of Directors of the Company, at its meeting held on May 25, 2026, inter alia, considered and approved the same.
Entero Healthcare Solutions is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.
| Company Name | CMP |
|---|---|
| Redington | 241.75 |
| Amrapali Industries | 18.55 |
| Adani Enterprises | 3037.95 |
| Rashi Peripheral | 542.75 |
| PDS | 319.30 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: